389 related articles for article (PubMed ID: 35276080)
21. Bacteriophage-mediated manipulation of the gut microbiome - promises and presents limitations.
Rasmussen TS; Koefoed AK; Jakobsen RR; Deng L; Castro-Mejía JL; Brunse A; Neve H; Vogensen FK; Nielsen DS
FEMS Microbiol Rev; 2020 Jul; 44(4):507-521. PubMed ID: 32495834
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy of curcumin and fecal microbiota transplant: Potential treatment of polycystic ovarian syndrome.
Corrie L; Gulati M; Vishwas S; Kapoor B; Singh SK; Awasthi A; Khursheed R
Med Hypotheses; 2021 Sep; 154():110644. PubMed ID: 34332209
[TBL] [Abstract][Full Text] [Related]
23. Effects of fecal microbiota transplantation and fecal virome transplantation on LPS-induced intestinal injury in broilers.
Wu D; Liang S; Du X; Xiao J; Feng H; Ren Z; Yang X; Yang X
Poult Sci; 2024 Feb; 103(2):103316. PubMed ID: 38128454
[TBL] [Abstract][Full Text] [Related]
24. Long-term microbiota and virome in a Zürich patient after fecal transplantation against Clostridium difficile infection.
Broecker F; Klumpp J; Moelling K
Ann N Y Acad Sci; 2016 May; 1372(1):29-41. PubMed ID: 27286042
[TBL] [Abstract][Full Text] [Related]
25. Manipulation of Gut Microbiota as a Key Target for Crohn's Disease.
Rashed R; Valcheva R; Dieleman LA
Front Med (Lausanne); 2022; 9():887044. PubMed ID: 35783604
[TBL] [Abstract][Full Text] [Related]
26. Promises of microbiome-based therapies.
Bajaj JS; Ng SC; Schnabl B
J Hepatol; 2022 Jun; 76(6):1379-1391. PubMed ID: 35589257
[TBL] [Abstract][Full Text] [Related]
27. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer.
Coker OO; Nakatsu G; Dai RZ; Wu WKK; Wong SH; Ng SC; Chan FKL; Sung JJY; Yu J
Gut; 2019 Apr; 68(4):654-662. PubMed ID: 30472682
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection.
Haifer C; Paramsothy S; Borody TJ; Clancy A; Leong RW; Kaakoush NO
mSystems; 2021 Feb; 6(1):. PubMed ID: 33531405
[TBL] [Abstract][Full Text] [Related]
29. Gut mycobiome in metabolic diseases: Mechanisms and clinical implication.
Zhou X; Zhang X; Yu J
Biomed J; 2023 Jun; ():100625. PubMed ID: 37364760
[TBL] [Abstract][Full Text] [Related]
30. The Human Gut Virome and Its Relationship with Nontransmissible Chronic Diseases.
Ezzatpour S; Mondragon Portocarrero ADC; Cardelle-Cobas A; Lamas A; López-Santamarina A; Miranda JM; Aguilar HC
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839335
[TBL] [Abstract][Full Text] [Related]
31. Stable core virome despite variable microbiome after fecal transfer.
Broecker F; Russo G; Klumpp J; Moelling K
Gut Microbes; 2017 May; 8(3):214-220. PubMed ID: 27935413
[TBL] [Abstract][Full Text] [Related]
32. Transplanting Fecal Virus-Like Particles Reduces High-Fat Diet-Induced Small Intestinal Bacterial Overgrowth in Mice.
Lin DM; Koskella B; Ritz NL; Lin D; Carroll-Portillo A; Lin HC
Front Cell Infect Microbiol; 2019; 9():348. PubMed ID: 31750259
[TBL] [Abstract][Full Text] [Related]
33. Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases.
Iliev ID; Cadwell K
Gastroenterology; 2021 Mar; 160(4):1050-1066. PubMed ID: 33347881
[TBL] [Abstract][Full Text] [Related]
34. The Unexplored World of Human Virome, Mycobiome, and Archaeome in Aging.
Barrera-Vázquez OS; Gomez-Verjan JC
J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(10):1834-1837. PubMed ID: 31802114
[TBL] [Abstract][Full Text] [Related]
35. Fecal microbiota transplantation alleviates myocardial damage in myocarditis by restoring the microbiota composition.
Hu XF; Zhang WY; Wen Q; Chen WJ; Wang ZM; Chen J; Zhu F; Liu K; Cheng LX; Yang J; Shu YW
Pharmacol Res; 2019 Jan; 139():412-421. PubMed ID: 30508676
[TBL] [Abstract][Full Text] [Related]
36. Impact of Early Life Nutrition on Children's Immune System and Noncommunicable Diseases Through Its Effects on the Bacterial Microbiome, Virome and Mycobiome.
Fragkou PC; Karaviti D; Zemlin M; Skevaki C
Front Immunol; 2021; 12():644269. PubMed ID: 33815397
[TBL] [Abstract][Full Text] [Related]
37. Profiling the Fungal Microbiome after Fecal Microbiota Transplantation for Graft-versus-Host Disease: Insights from a Phase 1 Interventional Study.
van Lier YF; Rolling T; Armijo GK; Zhai B; Haverkate NJE; Meijer E; Nur E; Blom B; Peled JU; van den Brink MRM; Hohl TM; Hazenberg MD; Markey KA
Transplant Cell Ther; 2023 Jan; 29(1):63.e1-63.e5. PubMed ID: 36280104
[TBL] [Abstract][Full Text] [Related]
38. Benefits of fecal microbiota transplantation: A comprehensive review.
Ademe M
J Infect Dev Ctries; 2020 Oct; 14(10):1074-1080. PubMed ID: 33175698
[TBL] [Abstract][Full Text] [Related]
39. Functional Restoration of Bacteriomes and Viromes by Fecal Microbiota Transplantation.
Fujimoto K; Kimura Y; Allegretti JR; Yamamoto M; Zhang YZ; Katayama K; Tremmel G; Kawaguchi Y; Shimohigoshi M; Hayashi T; Uematsu M; Yamaguchi K; Furukawa Y; Akiyama Y; Yamaguchi R; Crowe SE; Ernst PB; Miyano S; Kiyono H; Imoto S; Uematsu S
Gastroenterology; 2021 May; 160(6):2089-2102.e12. PubMed ID: 33577875
[TBL] [Abstract][Full Text] [Related]
40. The gut virome is associated with stress-induced changes in behaviour and immune responses in mice.
Ritz NL; Draper LA; Bastiaanssen TFS; Turkington CJR; Peterson VL; van de Wouw M; Vlckova K; Fülling C; Guzzetta KE; Burokas A; Harris H; Dalmasso M; Crispie F; Cotter PD; Shkoporov AN; Moloney GM; Dinan TG; Hill C; Cryan JF
Nat Microbiol; 2024 Feb; 9(2):359-376. PubMed ID: 38316929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
